Cargando…
Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer
BACKGROUND: Paxillin (PXN) has been found to be aberrantly regulated in various malignancies and involved in tumor growth and invasion. The clinicopathological and prognostic significance of PXN in gastric cancer is still unclear. METHODS: The expression of PXN was determined in paired gastric cance...
Autores principales: | Chen, Dong-liang, Wang, Zhi-qiang, Ren, Chao, Zeng, Zhao-lei, Wang, De-shen, Luo, Hui-yan, Wang, Feng, Qiu, Miao-zhen, Bai, Long, Zhang, Dong-sheng, Wang, Feng-hua, Li, Yu-hong, Xu, Rui-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228400/ https://www.ncbi.nlm.nih.gov/pubmed/24180516 http://dx.doi.org/10.1186/1479-5876-11-277 |
Ejemplares similares
-
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer
por: Chen, Dong-Liang, et al.
Publicado: (2013) -
Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
por: Jin, Ying, et al.
Publicado: (2013) -
Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer
por: Ren, Chao, et al.
Publicado: (2012) -
S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis
por: He, Ming-ming, et al.
Publicado: (2013) -
Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms
por: Wang, Zi-Xian, et al.
Publicado: (2016)